DUBLIN, May 25, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global RespiratoryDrugs Market 2016-2020" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO )
The global respiratory drugs market to grow at a CAGR of 6.48% during the period 2016-2020.
- AstraZeneca - Boehringer Ingelheim - F.Hoffman La-Roche - GlaxoSmithKline - Merck - Novartis Key Topics Covered: Part 01: Executive summary Part 02: Scope of the report Part 03: Market research methodology Part 04: Introduction Part 05: Overview: Respiratory diseases Part 06: Pipeline analysis Part 07: Market landscape Part 08: Market segmentation by class of drugs Part 09: Market segmentation by disease Part 10: Geographical segmentation Part 11: Market drivers Part 12: Impact of drivers Part 13: Market challenges Part 14: Impact of drivers and challenges Part 15: Market trends Part 16: Vendor landscape Part 17: Appendix For more information visit http://www.researchandmarkets.com/research/86g5tj/global
Media Contact: Laura Wood, Senior Manager firstname.lastname@example.org
For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Subscribe to our Free Newsletters!
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...
Unintended pregnancies are very common these days, and so one in about four pregnant women go for ...
Dizziness is a feeling of being faint or unsteady whereas Vertigo is a feeling that you or your ...View All